| Prev Close | 2.51 |
| Open | 2.55 |
| Day Low/High | 2.47 / 2.55 |
| 52 Wk Low/High | 2.01 / 11.62 |
| Volume | 98.74K |
| Avg Volume | 152.80K |
Celldex Therapeutics (CLDX) Stock Price Target Lowered at Cantor Fitzgerald
Cantor Fitzgerald reduced its price target on Celldex Therapeutics (CLDX) stock and maintained its ‘buy’ rating on Friday morning.
Celldex Therapeutics (CLDX) Stock Gaining on Q4 Results
Celldex Therapeutics (CLDX) stock is advancing on Thursday after the company reported a narrower loss than expected in the 2015 fourth quarter before today’s market open.
Celldex Reports Fourth Quarter And Year-End 2015 Results
Conference Call Scheduled for 8:00 a.m. ET Today
First Week of April 15th Options Trading For Celldex Therapeutics (CLDX)
Investors in Celldex Therapeutics, Inc. saw new options become available this week, for the April 15th expiration.
Today's Weak On High Volume Stock: Celldex Therapeutics (CLDX)
Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a weak on high relative volume candidate
'Mad Money' Lightning Round: I'm Not Going Against Amgen
Cramer is concerned about Omega Healthcare, expects a healthy quarter for Fitbit and isn't recommending Tesoro.
Jim Cramer's 'Mad Money' Recap: Time to Start Buying Cheap Stocks
Now's the time to roll up your sleeves and figure out what to buy, Cramer says. That job has been made easier by a strong earnings season.
Celldex To Report Fourth Quarter And Year-End 2015 Business/Financial Results And Host 2016 Corporate Strategy Conference Call
--Conference Call Scheduled for Thursday, February 25 at 8:00 a.m. Eastern Time--
Celldex Therapeutics is Now Oversold
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
Celldex Therapeutics (CLDX) In A Perilous Reversal
Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a "perilous reversal" (up big yesterday but down big today) candidate
Trade-Ideas: Celldex Therapeutics (CLDX) Is Today's "Dead Cat Bounce" Stock
Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a "dead cat bounce" (down big yesterday but up big today) candidate
Weak On High Volume: Celldex Therapeutics (CLDX)
Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a weak on high relative volume candidate
Celldex Nears Pivotal Decision Point for Brain Tumor Therapy
Celldex will announce the outcome of an interim analysis for a pivotal study of its brain tumor therapy Rintega within weeks.
Oversold Conditions For Celldex Therapeutics (CLDX)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
Celldex Therapeutics (CLDX) Highlighted As Weak On High Volume
Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a weak on high relative volume candidate
8 Things That Could Lift Biotech Stocks Out of Bear Market
Biotech stocks are buried in a deep hole. To climb out, companies will have to generate some positive news.
New 52-Week Low Could Prompt More Insider Buying At CLDX
In trading on Thursday, shares of Celldex Therapeutics, Inc. touched a new 52-week low of $9.66/share.
'Mad Money' Lightning Round: Buy, Buy, Buy Cedar Fair for the Yield
Cramer sees First Solar going higher and wants no part of Atwood Oceanics.
Jim Cramer's 'Mad Money' Recap: Oil Is What's Fueling This Market
Until oil prices stabilize, don't expect any meaningful relief in the stock market, Cramer says.
Celldex Therapeutics (CLDX) Highlighted As Weak On High Volume
Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a weak on high relative volume candidate
Today's Dead Cat Bounce Stock: Celldex Therapeutics (CLDX)
Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a "dead cat bounce" (down big yesterday but up big today) candidate
Cancer Immunotherapy ETF Offers High Growth Investing Potential
Immunotherapy is changing the way the medical community thinks about treating cancer.
Trade-Ideas: Celldex Therapeutics (CLDX) Is Today's "Dead Cat Bounce" Stock
Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a "dead cat bounce" (down big yesterday but up big today) candidate
Celldex Therapeutics (CLDX) Strong On High Relative Volume Today
Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a strong on high relative volume candidate
Trade-Ideas: Celldex Therapeutics (CLDX) Is Today's "Perilous Reversal" Stock
Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a "perilous reversal" (up big yesterday but down big today) candidate
4 Big-Volume Stocks to Trade for Big Gains
Here's how to trade four stocks spiking on increased trading volume.
Celldex Therapeutics (CLDX) Strong On High Relative Volume Today
Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a strong on high relative volume candidate
